Literature DB >> 3550414

Quantitative assessment of neuromuscular deficit in ALS.

P L Andres, L M Thibodeau, L J Finison, T L Munsat.   

Abstract

Several criteria must be met in developing a test battery forr ALS. First, the test items should be designed to answer the specific questions being asked. If questions involve the amount and rate of deterioration, then the test items should generate interval data and show evidence that they reflect change in the disease itself. Second, the reliability of the test items should be carefully determined. Are the variances due to testing errors such as inconsistent positioning or changes in verbal instructions; or do they reflect human performance variation? Third, the test items must be sensitive to small changes, and one must be able to test the very strong as well as the severely debilitated patient. The TQNE was designed to measure degree of disease progression in ALS. The major portion of the protocol consists of isometric force measurement using an electronic strain gauge. Other quantitative segments include tests of pulmonary function, speech rates, and timed activities. Using z-score transformations, we have summarized these test items into five megascores: pulmonary function, bulbar function, timed hand activities, arm strength, and leg strength. Megascores have been used to characterize the natural history of the disease and to judge therapeutic efficacy. Quantitative methods to measure deficit in neuromuscular disease lag far behind other technologic advances in medical research. Future advances in the measurement of neuromuscular deficit depend on the commitment of researchers to invest the time and resources necessary to develop more sensitive and reliable testing techniques.

Entities:  

Mesh:

Year:  1987        PMID: 3550414

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  6 in total

Review 1.  Measures and markers in amyotrophic lateral sclerosis.

Authors:  Merit Cudkowicz; Muhammad Qureshi; Jeremy Shefner
Journal:  NeuroRx       Date:  2004-04

2.  Electrical impedance myography in the evaluation of the tongue musculature in amyotrophic lateral sclerosis.

Authors:  Sanjana Shellikeri; Yana Yunusova; Jordan R Green; Gary L Pattee; James D Berry; Seward B Rutkove; Lorne Zinman
Journal:  Muscle Nerve       Date:  2015-06-03       Impact factor: 3.217

Review 3.  Strength Testing in Motor Neuron Diseases.

Authors:  Jeremy M Shefner
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

4.  CT muscle scanning in the evaluation of patients with spinal muscular atrophy (SMA).

Authors:  P Sambrook; D Rickards; W J Cumming
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

5.  Resistance strength training exercise in children with spinal muscular atrophy.

Authors:  Aga Lewelt; Kristin J Krosschell; Gregory J Stoddard; Cindy Weng; Mei Xue; Robin L Marcus; Eduard Gappmaier; Louis Viollet; Barbara A Johnson; Andrea T White; Donata Viazzo-Trussell; Philippe Lopes; Robert H Lane; John C Carey; Kathryn J Swoboda
Journal:  Muscle Nerve       Date:  2015-10       Impact factor: 3.217

6.  Quantitative strength testing in ALS clinical trials.

Authors:  Jeremy M Shefner; Dawei Liu; Melanie L Leitner; David Schoenfeld; Donald R Johns; Toby Ferguson; Merit Cudkowicz
Journal:  Neurology       Date:  2016-07-06       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.